The Hungarian government is working to open new crossing points at its border with Slovakia this week, Foreign Minister Péter Szijjártó said.
Eight new medicines recommended for approval
EMA has recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal muscular atrophy (SMA), a rare and often fatal genetic disease that causes muscle weakness and progressive loss of movement. There are currently limited treatment options for children with […]
EMA is aware of recent media reports and publications which question whether some medicines, for instance angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs, or sartan medicines), could worsen coronavirus disease (COVID-19). ACE inhibitors and ARBs are most commonly used for treating patients with high blood pressure, heart failure or kidney disease. It […]
It has been announced today (27th March) that Boris Johnson, British PM, is also infected.
In 2012 a consumer concluded with a credit institution, the Kreissparkasse Saarlouis, a credit agreement secured by mortgages for a sum of €100 000, at an annual borrowing rate of 3.61% fixed until 30 November 2021. The credit agreement provides that the borrower has a period of 14 days to withdraw, that period running from […]
A passenger who reserved his or her flight through a travel agency may bring an action for compensation for a long flight delay against the air carrier before thecourts of the place of departure of the flight
Hungary and Romania will reopen their shared border to commuters, the foreign minister said.
On Wednesday (25th March), the Royal Family announced that unfortunately, Prince Charles got the virus.
Global regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key […]